CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1

被引:122
作者
Toka, FN
Suvas, S
Rouse, BT
机构
[1] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA
[2] Agr Univ Warsaw, Immunol Lab, Dept Preclin Sci, Warsaw, Poland
关键词
D O I
10.1128/JVI.78.23.13082-13089.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It has become evident that naturally occurring CD25(+) regulatory T cells (T-reg cells) not only influence self-antigen specific immune response but also dampen foreign antigen specific immunity. This report extends our previous findings by demonstrating that immunity to certain herpes simplex virus (HSV) vaccines is significantly elevated and more effective if T-reg cell response is curtailed during either primary or recall immunization. The data presented here show that removal of CD25(+) T-reg cells prior to SSIEFARL-CpG or gB-DNA immunization significantly enhanced the resultant CD8(+) T-cell response to the immunodominant SSIEFARL peptide. The enhanced CD8(+) T-cell reactivity in T-reg cell-depleted animals was between two- and threefold and evident in both acute and memory stages. Interestingly, removal of CD25(+) T-reg cells during the memory recall response to plasmid immunization resulted in a twofold increase in CD8(+) T-cell memory pool. Moreover, in the challenge experiments, memory CD8(+) T cells generated with plasmid DNA in the absence of T-reg cells cleared the virus more effectively compared with control groups. We conclude that CD25(+) T-reg cells quantitatively as well as qualitatively affect the memory CD8(+) T-cell response generated by gB-DNA vaccination against HSV. However, it remains to be seen if all types of vaccines against HSV are similarly affected by CD25(+) T-reg cells and if it is possible to devise means of limiting T-reg cell activity to enhance vaccine efficacy.
引用
收藏
页码:13082 / 13089
页数:8
相关论文
共 25 条
[21]   Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses [J].
Sutmuller, RPM ;
van Duivenvoorde, LM ;
van Elsas, A ;
Schumacher, TNM ;
Wildenberg, ME ;
Allison, JP ;
Toes, REM ;
Offringa, R ;
Melief, CJM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) :823-832
[22]   CD4+CD25+T cells regulate virus-specific primary and memory CD8+T cell responses [J].
Suvas, S ;
Kumaraguru, U ;
Pack, CD ;
Lee, S ;
Rouse, BT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) :889-901
[23]   Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease [J].
Taguchi, O ;
Takahashi, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1608-1612
[24]   Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1 [J].
Toka, FN ;
Gierynska, M ;
Rouse, BT .
JOURNAL OF VIROLOGY, 2003, 77 (23) :12742-12752
[25]   Dynamic programming of CD8+ T lymphocyte responses [J].
van Stipdonk, MJB ;
Hardenberg, G ;
Bijker, MS ;
Lemmens, EE ;
Droin, NM ;
Green, DR ;
Schoenberger, SP .
NATURE IMMUNOLOGY, 2003, 4 (04) :361-365